Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Enveric Biosciences, Inc. (ENVB) had Return on Tangible Equity of -617.49% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-9.57M |
|
-- |
|
-- |
|
$9.63M |
|
$-9.63M |
|
$0.07M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-9.63M |
|
$-9.29M |
|
0.50M |
|
0.50M |
|
$-19.04 |
|
$-19.04 |
|
| Balance Sheet Financials | |
$2.73M |
|
$0.31M |
|
$0.35M |
|
$3.08M |
|
$1.49M |
|
-- |
|
-- |
|
$1.49M |
|
$1.59M |
|
$1.55M |
|
$1.59M |
|
0.68M |
|
| Cash Flow Statement Financials | |
$-7.73M |
|
-- |
|
$7.67M |
|
$2.29M |
|
$2.24M |
|
$-0.05M |
|
$1.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-601.14% |
|
|
Return on Tangible Equity |
-617.49% |
-310.62% |
|
-601.14% |
|
$2.35 |
|
$-15.36 |
|
$-15.36 |
|